Clinical trials in Granada – page 18

395 clinical trials in Granada, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Granada at a glance

395

clinical trials

Research sites2

Quick filters

395 trials in Granada

Open in trial search

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dulaglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Hidradenitis

Not recruiting

A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Investigational

A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:BFB759
Sponsor:Bluefin Biomedicine Inc.

Contact Research Centre

Hidradenitis

Not recruiting

A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Pfizer Inc.

Contact Research Centre

Hidradenitis

Not recruiting

Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

Investigational

Efficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Tulisokibart
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Investigational

Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Litifilimab
Sponsor:Biogen Idec Research Limited

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Breast cancer+3

Not recruiting

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Romiplostim
Sponsor:Amgen Inc.

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:AstraZeneca AB

Contact Research Centre

Dermatitis atopic

Not recruiting

A Study of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis Who Did Not Respond Well Enough to Dupilumab Treatment

Registered drugNo placebo

A Study of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis Who Did Not Respond Well Enough to Dupilumab Treatment

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Dupilumab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Breast cancer+2

Not recruiting

A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer

InvestigationalNo placebo

A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Disitamab Vedotin
Sponsor:Pfizer Inc.

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Study of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer

Registered drugNo placebo

Study of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Gozetotide
Sponsor:Novartis Pharma AG

Contact Research Centre

Hidradenitis

Not recruiting

Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

Investigational

Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ruxolitinib
Sponsor:Incyte Corp.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Granada

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on multiple cancer types including colorectal cancer, breast cancer, and glioblastoma. Studies are evaluating novel treatment approaches and combination therapies.

Metastatic colorectal cancer treatment optimization
Triple-negative breast cancer therapies
Prostate cancer diagnostics and treatment

Advanced imaging techniques and targeted therapies are being investigated to improve patient outcomes.

02 Respiratory Medicine

Research targeting respiratory conditions with a focus on chronic obstructive pulmonary disease. Studies are examining new therapeutic approaches for moderate to severe cases.

COPD exacerbation management
Novel therapeutic antibodies
Bronchial disease treatments

Emphasis on reducing disease progression and improving quality of life for patients.

03 Dermatology Studies

Clinical investigations in various skin conditions including plaque psoriasis and atopic dermatitis. Research focuses on innovative biological treatments.

Moderate to severe psoriasis therapies
Hidradenitis suppurativa treatments
Novel dermatological interventions

Trials aim to develop more effective treatments for chronic skin conditions.

04 Neurological Research

Studies investigating treatments for Alzheimer's disease in specific populations, particularly focusing on prevention and management of associated conditions.

Alzheimer's disease in Down syndrome
Seizure prevention strategies
Neurological disorder management

Research aims to improve quality of life for patients with complex neurological conditions.

Back to Spain All countries